These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 8168635)

  • 41. Lack of autoimmune serological reactions in rodent models of insulin dependent diabetes mellitus.
    Mackay IR; Bone A; Tuomi T; Elliott R; Mandel T; Karopoulos C; Rowley MJ
    J Autoimmun; 1996 Dec; 9(6):705-11. PubMed ID: 9115572
    [TBL] [Abstract][Full Text] [Related]  

  • 42. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function.
    Cameron MJ; Arreaza GA; Zucker P; Chensue SW; Strieter RM; Chakrabarti S; Delovitch TL
    J Immunol; 1997 Nov; 159(10):4686-92. PubMed ID: 9366391
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical review 103: T helper type 1 and 2 cytokines mediate the onset and progression of type I (insulin-dependent) diabetes.
    Almawi WY; Tamim H; Azar ST
    J Clin Endocrinol Metab; 1999 May; 84(5):1497-502. PubMed ID: 10323367
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular role of TGF-beta, secreted from a new type of CD4+ suppressor T cell, NY4.2, in the prevention of autoimmune IDDM in NOD mice.
    Han HS; Jun HS; Utsugi T; Yoon JW
    J Autoimmun; 1997 Jun; 10(3):299-307. PubMed ID: 9218758
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Islet-infiltrating T cell clones from non-obese diabetic mice that promote or prevent accelerated onset diabetes.
    Pankewycz O; Strom TB; Rubin-Kelley VE
    Eur J Immunol; 1991 Apr; 21(4):873-9. PubMed ID: 1902177
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evidence that Th1 lymphocytes predominate in islet inflammation and thyroiditis in the BioBreeding (BB) rat.
    Zipris D
    J Autoimmun; 1996 Jun; 9(3):315-9. PubMed ID: 8816966
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The contribution of animal models to the understanding of the pathogenesis of type 1 diabetes.
    Carnaud C
    Braz J Med Biol Res; 1995 Aug; 28(8):925-9. PubMed ID: 8555997
    [TBL] [Abstract][Full Text] [Related]  

  • 48. β-cell-specific IL-35 therapy suppresses ongoing autoimmune diabetes in NOD mice.
    Manzoor F; Johnson MC; Li C; Samulski RJ; Wang B; Tisch R
    Eur J Immunol; 2017 Jan; 47(1):144-154. PubMed ID: 27859048
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic and immunological basis of autoimmune diabetes in the NOD mouse.
    Yoshida K; Kikutani H
    Rev Immunogenet; 2000; 2(1):140-6. PubMed ID: 11324686
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combination therapy with sirolimus and interleukin-2 prevents spontaneous and recurrent autoimmune diabetes in NOD mice.
    Rabinovitch A; Suarez-Pinzon WL; Shapiro AM; Rajotte RV; Power R
    Diabetes; 2002 Mar; 51(3):638-45. PubMed ID: 11872661
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevention of type 1 diabetes.
    Rabinovitch A; Skyler JS
    Med Clin North Am; 1998 Jul; 82(4):739-55. PubMed ID: 9706119
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tolerance to islet autoantigens in type 1 diabetes.
    Bach JF; Chatenoud L
    Annu Rev Immunol; 2001; 19():131-61. PubMed ID: 11244033
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice.
    Wogensen L; Lee MS; Sarvetnick N
    J Exp Med; 1994 Apr; 179(4):1379-84. PubMed ID: 8145050
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Humoral autoimmunity in the pathogenesis of insulin-dependent diabetes mellitus. Studies in the spontaneously diabetic BB rat.
    Dyrberg T
    Acta Endocrinol Suppl (Copenh); 1986; 280():1-29. PubMed ID: 2429489
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Potential mechanisms by which certain foods promote or inhibit the development of spontaneous diabetes in BB rats: dose, timing, early effect on islet area, and switch in infiltrate from Th1 to Th2 cells.
    Scott FW; Cloutier HE; Kleemann R; Wöerz-Pagenstert U; Rowsell P; Modler HW; Kolb H
    Diabetes; 1997 Apr; 46(4):589-98. PubMed ID: 9075798
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antigen-specific mediated suppression of beta cell autoimmunity by plasmid DNA vaccination.
    Tisch R; Wang B; Weaver DJ; Liu B; Bui T; Arthos J; Serreze DV
    J Immunol; 2001 Feb; 166(3):2122-32. PubMed ID: 11160264
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The thymus as a site for evaluating the potency of candidate beta cell autoantigens in NOD mice.
    Gerling IC; Atkinson MA; Leiter EH
    J Autoimmun; 1994 Dec; 7(6):851-8. PubMed ID: 7888041
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunization of non-obese diabetic (NOD) mice with glutamic acid decarboxylase-derived peptide 524-543 reduces cyclophosphamide-accelerated diabetes.
    Saï P; Rivereau AS; Granier C; Haertlé T; Martignat L
    Clin Exp Immunol; 1996 Aug; 105(2):330-7. PubMed ID: 8706342
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neonatal activation of CD28 signaling overcomes T cell anergy and prevents autoimmune diabetes by an IL-4-dependent mechanism.
    Arreaza GA; Cameron MJ; Jaramillo A; Gill BM; Hardy D; Laupland KB; Rapoport MJ; Zucker P; Chakrabarti S; Chensue SW; Qin HY; Singh B; Delovitch TL
    J Clin Invest; 1997 Nov; 100(9):2243-53. PubMed ID: 9410902
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low dose poly I:C prevents diabetes in the diabetes prone BB rat.
    Sobel DO; Goyal D; Ahvazi B; Yoon JW; Chung YH; Bagg A; Harlan DM
    J Autoimmun; 1998 Aug; 11(4):343-52. PubMed ID: 9776712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.